LXRX logo

Lexicon Pharmaceuticals, Inc. (LXRX)

Profile

Full Name

Lexicon Pharmaceuticals, Inc.

Ticker

NASDAQ: LXRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 7, 2000

Indexes

Not included

Website

https://www.lexpharma.com

Employees

103

Key Details

Price

$1.30(-1.52%)

Market Cap

$472.42M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$31.08M(2481.48% YoY)

Annual EPS

-$0.63(21.82% YoY)

PE Ratio

-

Next earnings date

Mar 5, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.30
    LXRX price is $1.30

    30-Day Relative Volume

    0.54
    LXRX 30-day relative volume is 0.54

    Price Performance

    Price Most Recent Change

    -1.52%
    LXRX price was down -1.52% on Dec 12, 2025

    Price YTD Change

    +75.68%
    LXRX price is up +75.68% since January 1st

    Price 1-Year Change

    +58.54%
    LXRX price is up +58.54% year-on-year

    Price 3-Year Change

    -38.68%
    LXRX price is down -38.68% over the past 3 years

    Price Range

    Price All-Time High

    $344.75
    LXRX price is currently -99.62% below its historical high of $344.75

    Price 3-Year Low

    $0.28
    LXRX price is currently +364.29% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $472.42M
    LXRX market cap is $472.42 million

    Market Cap 3-Year Change

    +18.08%
    LXRX market cap is up +18.08% over the past 3 years

    Market Cap All-Time High

    $2.25B
    LXRX market cap is currently -78.96% below its historical high of $2.25 billion

    Market Cap Sector Percentile

    61.06%
    LXRX market cap is higher than 61.06% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.53%
    LXRX shares outstanding is up +0.53% year-on-year

    Shares Outstanding 3-Year Change

    +92.55%
    LXRX shares outstanding is up +92.55% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.88
    LXRX beta is 0.88

    200-day SMA

    $0.97
    LXRX price is currently +33.40% above its 200-day simple moving average

    50-day SMA

    $1.42
    LXRX price is currently -8.23% below its 50-day simple moving average

    14-Day RSI

    42.49
    LXRX 14-day relative strength index is 42.49

    Volume

    0.54
    LXRX 30-day relative volume is 0.54

    ATR

    $0.09
    LXRX average true range is $0.09

    10-day Historical Volatility

    46.90%
    LXRX 10-day historical volatility is 46.90%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $31.08M
    LXRX annual revenue is $31.08 million

    Revenue Analysts Estimate

    $47.46M
    LXRX annual revenue is currently -34.51% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +2481.48%
    LXRX annual revenue is up +2481.48% year-on-year

    Revenue Sector Percentile

    57.13%
    LXRX annual revenue is higher than 57.13% of companies in Healthcare sector

    EPS

    EPS

    -$0.63
    LXRX annual earnings per share is -$0.63

    EPS Analysts Estimate

    -$0.17
    LXRX annual earnings per share is currently -275.19% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +21.82%
    LXRX annual earnings per share is up +21.82% year-on-year

    EPS Sector Percentile

    64.2%
    LXRX annual earnings per share is higher than 64.2% of companies in Healthcare sector

    Profit

    Gross Profit

    $29.93M
    LXRX annual gross profit is $29.93 million

    Gross Margin

    96.30%
    LXRX annual gross profit margin is 96.30%

    Operating Profit

    -$184.82M
    LXRX annual operating income is -$184.82 million

    Operating Margin

    -594.63%
    LXRX annual operating profit margin is -594.63%

    Net Income

    -$200.40M
    LXRX annual net profit is -$200.40 million

    Net Margin

    -644.78%
    LXRX annual net profit margin is -644.78%

    Expenses

    Total Expenses

    $231.48M
    LXRX annual total expenses is $231.48 million

    Operating Expenses

    $214.75M
    LXRX annual total operating expenses is $214.75 million

    Cost Of Goods Sold

    $1.15M
    LXRX annual cost of goods sold is $1.15 million

    Selling, General & Administrative Expenses

    $0.00
    LXRX annual SG&A is $0.00

    Depreciation & Amortization

    $534.00K
    LXRX annual D&A is $534.00 thousand

    Interest Expense

    $0.00
    LXRX annual interest expense is $0.00

    Income Tax

    $0.00
    LXRX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$184.82M
    LXRX annual earnings before interest & taxes is -$184.82 million

    EBITDA

    -$184.28M
    LXRX annual EBITDA is -$184.28 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $298.42M
    LXRX annual total assets is $298.42 million

    Non Current Assets

    $52.23M
    LXRX annual long term assets is $52.23 million

    Current Assets

    $246.19M
    LXRX annual total current assets is $246.19 million

    Cash and Cash Equivalents

    $237.96M
    LXRX annual cash & cash equivalents is $237.96 million

    Accounts Receivable

    $3.47M
    LXRX annual accounts receivable is $3.47 million

    Inventory

    $231.00K
    LXRX annual inventory is $231.00 thousand

    Liabilities

    Total Liabilities

    $152.47M
    LXRX annual total liabilities is $152.47 million

    Long Term Liabilities

    $107.22M
    LXRX annual total long term liabilities is $107.22 million

    Current Liabilities

    $45.25M
    LXRX annual current liabilities is $45.25 million

    Accounts Payable

    $14.80M
    LXRX annual accounts payable is $14.80 million

    Debt

    Total Debt

    $106.07M
    LXRX annual total debt is $106.07 million

    Total Debt 1-Year Change

    +0.01%
    LXRX annual total debt is up +0.01% year-on-year

    Long Term Debt

    $104.90M
    LXRX annual long term debt is $104.90 million

    Short Term Debt

    $1.18M
    LXRX annual short term debt is $1.18 million

    Equity & Capital

    Shareholders Equity

    $145.95M
    LXRX annual stockholders equity is $145.95 million

    Book Value

    $145.95M
    LXRX annual book value is $145.95 million

    Retained Earnings

    -$1.97B
    LXRX annual retained earnings is -$1.97 billion

    Working Capital

    $200.94M
    LXRX annual working capital is $200.94 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$180.09M
    LXRX annual cash from operations is -$180.09 million

    Cash From Operations 1-Year Change

    -11.24%
    LXRX annual cash from operations is down -11.24% year-on-year

    Cash From Investing

    -$15.38M
    LXRX annual cash from investing is -$15.38 million

    Cash From Investing 1-Year Change

    +69.21%
    LXRX annual cash from investing is up +69.21% year-on-year

    Cash From Financing

    $239.66M
    LXRX annual cash from financing is $239.66 million

    Cash From Financing 1-Year Change

    +27.5%
    LXRX annual cash from financing is up +27.5% year-on-year

    CAPEX

    CAPEX

    $1.03M
    LXRX annual capital expenditures is $1.03 million

    CAPEX 1-Year Change

    +119.36%
    LXRX annual capital expenditures is up +119.36% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$181.12M
    LXRX annual free cash flow is -$181.12 million

    Free Cash Flow 1-Year Change

    -11.55%
    LXRX annual free cash flow is down -11.55% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    96.30%
    LXRX annual gross profit margin is 96.30%

    Operating Margin

    -594.63%
    LXRX annual operating profit margin is -594.63%

    Net Margin

    -644.78%
    LXRX annual net profit margin is -644.78%

    ROA & ROE

    ROA

    -75.93%
    LXRX annual return on assets is -75.93%

    ROE

    -167.66%
    LXRX annual return on equity is -167.66%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    LXRX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    LXRX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    3.93
    LXRX price to book ratio is 3.93

    PB Ratio Sector Percentile

    68.67%
    LXRX price to book ratio is higher than 68.67% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    6.67
    LXRX price to sales ratio is 6.67

    PS Ratio Sector Percentile

    62.35%
    LXRX price to sales ratio is higher than 62.35% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $421.41M
    LXRX enterprise value is $421.41 million

    Enterprise Value Sector Percentile

    61.31%
    LXRX enterprise value is higher than 61.31% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -7.35
    LXRX EV/EBITDA is -7.35

    EV/EBITDA Sector Percentile

    19.53%
    LXRX EV/EBITDA is higher than 19.53% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    5.44
    LXRX annual current ratio is 5.44

    Quick Ratio

    5.44
    LXRX annual quick ratio is 5.44

    Leverage

    Debt To Equity

    0.73
    LXRX annual debt to equity ratio is 0.73

    Interest Coverage Ratio

    -
    LXRX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    3
    LXRX piotroski f-score is 3

    Altman Z-Score

    -8.50
    LXRX altman z-score is -8.50

    Analyst ratings

    Recent major analysts updates

    Sep 2, 25 HC Wainwright & Co.
    Buy
    Aug 7, 25 Citigroup
    Buy
    Jun 24, 25 HC Wainwright & Co.
    Buy
    Mar 28, 25 HC Wainwright & Co.
    Buy
    Mar 7, 25 Piper Sandler
    Overweight
    Mar 7, 25 Needham
    Hold
    Mar 7, 25 HC Wainwright & Co.
    Buy
    Mar 4, 25 Leerink Partners
    Market Perform
    Mar 3, 25 Needham
    Hold
    Mar 3, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with LXRX included

    Growing Shares Outstanding
    US stocks
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Lexicon Pharmaceuticals, Inc.?
    • Does Lexicon Pharmaceuticals, Inc. pay dividends?
    • What sector is Lexicon Pharmaceuticals, Inc. in?
    • What industry is Lexicon Pharmaceuticals, Inc. in?
    • What country is Lexicon Pharmaceuticals, Inc. based in?
    • When did Lexicon Pharmaceuticals, Inc. go public?
    • Is Lexicon Pharmaceuticals, Inc. in the S&P 500?
    • Is Lexicon Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Lexicon Pharmaceuticals, Inc. in the Dow Jones?
    • When was Lexicon Pharmaceuticals, Inc.'s last earnings report?
    • When does Lexicon Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Lexicon Pharmaceuticals, Inc.?

    The ticker symbol for Lexicon Pharmaceuticals, Inc. is NASDAQ:LXRX

    Does Lexicon Pharmaceuticals, Inc. pay dividends?

    No, Lexicon Pharmaceuticals, Inc. does not pay dividends

    What sector is Lexicon Pharmaceuticals, Inc. in?

    Lexicon Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Lexicon Pharmaceuticals, Inc. in?

    Lexicon Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Lexicon Pharmaceuticals, Inc. based in?

    Lexicon Pharmaceuticals, Inc. is headquartered in United States

    When did Lexicon Pharmaceuticals, Inc. go public?

    Lexicon Pharmaceuticals, Inc.'s initial public offering (IPO) was on April 7, 2000

    Is Lexicon Pharmaceuticals, Inc. in the S&P 500?

    No, Lexicon Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Lexicon Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Lexicon Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Lexicon Pharmaceuticals, Inc. in the Dow Jones?

    No, Lexicon Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Lexicon Pharmaceuticals, Inc.'s last earnings report?

    Lexicon Pharmaceuticals, Inc.'s most recent earnings report was on November 6, 2025

    When does Lexicon Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Lexicon Pharmaceuticals, Inc. is March 5, 2026
    On this page